• COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
Buy Tests
  • COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
  • BUY TESTS
COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025

COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025

by Oceanit | Dec 12, 2024 | Future, Government, International News

COVID-19 Impact: Hardest Hit Countries and Those Still Struggling in 2025 Global Impact of COVID-19: Countries Hardest Hit and Those Still Struggling in 2025 The COVID-19 pandemic has left a profound impact on nations worldwide, with some countries experiencing...
Can Children Use Rapid Home Tests? Guidelines, Ages, and Recommendations

Can Children Use Rapid Home Tests? Guidelines, Ages, and Recommendations

by Oceanit | Dec 12, 2024 | General, Government

Can Children Use Rapid Home Tests? Guidelines, Ages, and Recommendations As COVID-19 continues to affect communities worldwide, rapid home tests have become an essential tool for managing public health. These tests provide a convenient way to detect SARS-CoV-2...
What If I Have COVID-19 Symptoms but Test Negative? Guidelines for Isolation and Retesting

What If I Have COVID-19 Symptoms but Test Negative? Guidelines for Isolation and Retesting

by Oceanit | Dec 11, 2024 | General, Government

What If I Have COVID-19 Symptoms but Test Negative? Guidelines for Isolation and Retesting What If I Have Symptoms but Test Negative? Guidelines for Isolation, Retesting, and Seeking Care Experiencing symptoms of COVID-19 but receiving a negative rapid test result can...
COVID-19 Treatment Options and Eligibility Criteria in 2024

COVID-19 Treatment Options and Eligibility Criteria in 2024

by Oceanit | Dec 9, 2024 | Government, National News

COVID-19 Treatment Options and Eligibility Criteria in 2024 As of December 2024, the management of COVID-19 has evolved with the development of various treatment options aimed at reducing the severity of the disease and preventing complications. This article provides...
The Economic Consequences of COVID-19: Global and Local Impacts on Economies

The Economic Consequences of COVID-19: Global and Local Impacts on Economies

by Oceanit | Dec 5, 2024 | General, Government, Local News

The Economic Consequences of COVID-19: Global and Local Impacts on Economies The COVID-19 pandemic has profoundly disrupted economies worldwide, leading to unprecedented job losses, widespread business closures, and complex recovery challenges. This article examines...
Latest COVID Testing Guidelines: When Should Individuals Get Tested and What Types of Tests Are Recommended?

Latest COVID Testing Guidelines: When Should Individuals Get Tested and What Types of Tests Are Recommended?

by Oceanit | Dec 5, 2024 | Government, National News

Latest COVID Testing Guidelines: When Should Individuals Get Tested and What Types of Tests Are Recommended? COVID-19 testing remains a cornerstone of pandemic management, helping to curb the spread of SARS-CoV-2. The Centers for Disease Control and Prevention (CDC)...
« Older Entries
Next Entries »

Recent Posts

  • New 2025 COVID Vaccine Rules: What They Mean for Americans
  • Summer 2025 COVID Trends: What to Know & How to Stay Safe
  • CDC Updates 2025 COVID-19 Testing, Isolation & Recovery
  • WHO Pandemic Treaty Aims to Prevent Future Health Crises
  • Should You Keep Rapid Tests for Spring & Summer 2025?

Recent Comments

No comments to show.
Copyright 2025 Oceanit Foundry LLC. The ASSURE-100 Rapid COVID-19 Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ยง 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
  • Privacy Policy